The phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway represents one of the most frequently dysregulated signaling cascades in human cancers, promoting cell survival, growth, proliferation, and metabolism while inhibiting apoptosis [49,51]. The gene discussed is AKT1; the disease is cancer.